Management of regional lymph nodes in patients with malignant melanoma: Questionnaire survey of UK current practice

British Journal of Plastic Surgery

Volumn 55, Issue 5, 2002, Pages 372-375

  Lens, Marko B ^a   Dawes, Martin ^a   Goodacre, Tim ^a   Newton Bishop, Julia A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Melanoma; Regional lymph nodes; Survey; Treatment

Indexed keywords

ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; HEALTH CENTER; HEALTH SURVEY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL PRACTICE; MELANOMA; NATIONAL HEALTH SERVICE; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGISTER; SENTINEL LYMPH NODE BIOPSY; UNITED KINGDOM;

EID: 0036036358     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjps.2002.3861     Document Type: Article

References (16)

1. Sentinel lymph node biopsy for melanoma: Controversy despite widespread agreement
2. UK guidelines for the management of cutaneous melanoma
3. Formal axillary dissection
4. Sentinel lymph-node biopsy in the UK
5. Lymphatic mapping and sentinel lymphadenectomy for melanoma: Past, present, and future
6. Elective lymph node dissection in patients with melanoma: Systematic review and meta-analysis of randomized controlled trials
7. The argument against sentinel node biopsy for malignant melanoma
8. Towards quality assurance of the sentinel node procedure in malignant melanoma patients: A single institution evaluation and a European survey
9. Sentinel node detection in malignant melanoma
10. The Augsburg Consensus: Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies
11. Current practice and future directions in pathology and laboratory evaluation of the sentinel node
12. Principles of sentinel lymph node identification: Background and clinical implications
13. Malignant melanoma an update
14. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma
15. In support of sentinel node biopsy as a standard of care for patients with malignant melanoma
16. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma